Losartan is typically started at 50 mg once daily for most adults with high blood pressure, with the option to increase to 100 mg if blood pressure remains above target after several weeks. That straightforward range covers the majority of prescriptions, but the full dosing picture is more nuanced: the right amount depends on why you’re taking it, how your liver processes the drug, whether you’re also on other medications, and sometimes your genetic makeup. In heart failure, for instance, doses can climb to 150 mg daily, while children receive weight-based amounts that look nothing like adult regimens.
The Standard Adult Dose for High Blood Pressure
For most adults with high blood pressure, the starting dose is 50 mg taken once a day. If that doesn’t bring your blood pressure down enough after about three to six weeks, your prescriber will typically double it to 100 mg once daily. A trial of 366 patients with an average sitting diastolic pressure around 101 mmHg compared a fixed 50 mg dose to a group that started at 50 mg and could be bumped to 100 mg if diastolic pressure hadn’t dropped below 90 mmHg after six weeks.1PubMed. Comparative antihypertensive effects of losartan 50 mg and losartan 50 mg titrated to 100 mg in patients with essential hypertension That titration approach is still the backbone of how the drug is prescribed today.
There is one important exception at the low end: people with reduced liver function or significant volume depletion (from heavy diuretic use, for example) generally start at 25 mg once daily. The liver is central to how losartan works, a point explored further below, so impaired liver function means higher drug levels in the blood from any given dose. Starting lower and adjusting upward reduces the chance of a blood pressure drop that’s too steep.
Why the Liver Matters So Much for Losartan Dosing
Losartan is what pharmacologists call a prodrug. The tablet you swallow has some blood-pressure-lowering activity on its own, but most of the heavy lifting is done by a metabolite your liver creates, commonly called E-3174 (or EXP3174). This metabolite binds to the target receptor roughly five times more tightly than losartan itself.2PubMed. Pharmacokinetic-pharmacodynamic relations of losartan and EXP3174 in a porcine animal model That conversion happens primarily through a liver enzyme called CYP2C9, with some contribution from CYP3A4.3PubMed. Clinical pharmacokinetics of losartan
This has two practical consequences. First, anything that slows down CYP2C9 can reduce how much active metabolite your body produces, potentially weakening the drug’s effect. The antifungal fluconazole is one well-documented example: it inhibits CYP2C9 and measurably reduces the conversion of losartan to E-3174, raising the possibility of a diminished blood-pressure response.4PubMed. Fluconazole but not itraconazole decreases the metabolism of losartan to E-3174 Interestingly, itraconazole, another antifungal, does not have this effect because it works on a different enzyme pathway.
Second, people whose CYP2C9 genes carry certain variants (known as *2 or *3 alleles) convert losartan to its active metabolite more slowly. A meta-analysis found that carriers of these variants had higher blood levels of losartan itself but lower levels of the active metabolite, along with a longer time for both to clear the body.5PubMed Central. Influence of CYP2C9 Genetic Polymorphisms on the Pharmacokinetics of Losartan and Its Active Metabolite E-3174: A Systematic Review and Meta-Analysis In a clinical study of patients with kidney disease and diabetes, those with variant CYP2C9 genotypes showed a markedly different blood pressure response compared to those with the normal genotype.6PubMed Central. CYP2C9 Genotype and Pharmacodynamic Responses to Losartan in Patients with Primary and Secondary Kidney Diseases This doesn’t mean genetic testing is required before starting losartan, but it’s one reason some people respond robustly at 50 mg while others seem to need the full 100 mg or still don’t hit their target.
Higher Doses in Heart Failure
Heart failure dosing follows a different logic than hypertension dosing. In this setting, the goal isn’t only to lower blood pressure but to reduce the strain on a weakened heart and slow the cycle of fluid retention and hospital admissions. The landmark HEAAL trial compared 150 mg daily to 50 mg daily in nearly 3,800 patients with heart failure and reduced heart function who couldn’t tolerate ACE inhibitors. Over a median follow-up of about 4.7 years, about 43% of those on the higher dose died or were hospitalized for heart failure, compared with 46% on the lower dose. That translated to a roughly 10% lower risk with the 150 mg dose. Heart failure hospitalizations specifically dropped by about 13% in the high-dose group.7PubMed. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
The takeaway from HEAAL was clear: pushing the dose higher in heart failure patients confers real clinical benefit beyond what the standard hypertension dose achieves. But the trade-off is also real. More patients on 150 mg experienced kidney function changes, low blood pressure, and elevated potassium levels compared with the 50 mg group. High-dose losartan decreased the risk of low potassium but increased the risk of high potassium by about 21%.8PubMed. High- Versus Low-dose Losartan and Serum Potassium: An Analysis From HEAAL This is why heart failure patients on higher doses need regular blood work to monitor kidney function and potassium. The up-titration is worthwhile, but it’s not free of risk.
Kidney Protection in Diabetes
Losartan earned a specific approval for slowing kidney damage in people with type 2 diabetes and protein in the urine, based on the RENAAL trial. That study enrolled over 1,500 patients who took losartan at 50 to 100 mg daily on top of their other blood pressure medications for an average of about 3.4 years. Protein leakage into the urine dropped by about 35% with losartan compared to placebo.9PubMed. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy A subsequent analysis of the same trial data found that losartan reduced urine albumin by about 28% within the first six months, and that this antiproteinuric effect accounted for essentially all of the drug’s kidney-protective benefit beyond what blood pressure lowering alone could explain.10PubMed. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL
The dosing in this context typically starts at 50 mg and is pushed to 100 mg, paralleling the hypertension range. The lesson here is that the kidney-protective effect appears to be partly independent of blood pressure itself, which is why clinicians aim for the full 100 mg even if blood pressure is already controlled at the lower dose.
Dosing for Older Adults and People with Kidney Problems
One of losartan’s practical advantages is that it requires no dose adjustment for age alone. A review focused specifically on elderly patients found no need to modify the dose in older adults or in those with mild to moderate kidney dysfunction, and noted that the risk of a first-dose blood pressure drop is low.11PubMed. Losartan: a review of its use, with special focus on elderly patients This is a meaningful distinction from some other blood pressure medications, particularly ACE inhibitors, which can cause more pronounced first-dose effects in elderly or dehydrated patients.
Even at the extreme end of kidney disease, dosing stays remarkably stable. A pharmacokinetic study of patients on dialysis found that losartan and its active metabolite are minimally altered in end-stage kidney disease. No dose adjustment is needed, and because the drug and its metabolite barely pass through dialysis membranes, patients don’t need an extra dose after a dialysis session.12PubMed. Pharmacokinetics and blood pressure response of losartan in end-stage renal disease The main caveat for any patient with impaired kidneys remains potassium monitoring, since losartan can raise potassium levels regardless of the dose.
Pediatric Dosing
Children aren’t dosed in milligrams per day the way adults are. Instead, losartan dosing in kids is weight-based, typically starting around 0.7 mg per kilogram of body weight per day. A dose-response study in hypertensive children aged six months to six years tested three tiers: 0.1, 0.3, and 0.7 mg/kg per day, with the option to go as high as 1.4 mg/kg per day (capped at 100 mg) if blood pressure targets weren’t met. All three doses produced meaningful drops in blood pressure, though the study did not find a clear relationship between dose and response, and the drug was well tolerated across the range.13PubMed Central. A Randomized, Open-Label, Dose-Response Study of Losartan in Hypertensive Children
In older children, a separate trial found that a once-daily starting dose of about 0.75 mg/kg (up to 50 mg) lowered diastolic blood pressure within three weeks, and doses up to about 1.44 mg/kg per day (up to 100 mg) were generally well tolerated.14PubMed. A double-blind, dose-response study of losartan in hypertensive children For children being treated specifically for protein in the urine (proteinuria), a trial used a starting dose of about 0.7 mg/kg per day, titrated up to approximately 1.4 mg/kg per day within two weeks, with individualization based on how well the child tolerated the drug.15PubMed Central. Randomized, Double-Blind, Controlled Study of Losartan in Children with Proteinuria
Combination Tablets and Add-On Therapy
When losartan alone isn’t enough, combining it with other medications is the next step. The most common pairing is with hydrochlorothiazide (HCTZ), a diuretic, available as a single tablet. The two standard fixed-dose combinations are losartan 50 mg with HCTZ 12.5 mg, and losartan 100 mg with HCTZ 25 mg. Both produced significantly greater blood pressure reductions than HCTZ alone, with a clear dose-response pattern: the higher combination lowered daytime blood pressure by about 5.8/3.4 mmHg more than what had been achieved with prior treatment.16PubMed. Antihypertensive effects of two fixed-dose combinations of losartan and hydrochlorothiazide versus hydrochlorothiazide monotherapy in subjects with ambulatory systolic hypertension
A Japanese trial tested adding amlodipine (a calcium channel blocker) to the losartan/HCTZ combination in patients whose blood pressure was still uncontrolled. The triple combination of losartan 50 mg, HCTZ 12.5 mg, and amlodipine 5 mg produced significantly better blood pressure reduction than the two-drug combination, and the benefit held over 44 weeks of follow-up.17PubMed. Efficacy and safety of fixed-dose losartan/hydrochlorothiazide/amlodipine combination versus losartan/hydrochlorothiazide combination in Japanese patients with essential hypertension These stepwise additions are common in practice: losartan alone first, then a combination tablet, then potentially a third agent if blood pressure remains stubborn.
Once a Day or Twice a Day
Losartan’s official labeling calls for once-daily dosing, but there’s a wrinkle. The drug’s half-life is relatively short compared to some other medications in its class, and some clinicians split the daily dose into two administrations to maintain more consistent blood pressure control over the full 24-hour cycle. A study comparing once-daily evening dosing to twice-daily dosing found that splitting the same total daily dose across two administrations appeared more effective at correcting the “non-dipper” pattern, where blood pressure doesn’t drop appropriately at night.18PubMed. Treatment of Hypertension: Favourable Effect of the Twice-Daily Compared to the Once-Daily (Evening) Administration of Perindopril and Losartan
Real-world data paints a slightly more complex picture. A large observational study found that patients taking losartan twice daily (splitting 50 mg into 25 mg twice, or splitting 100 mg into 50 mg twice) had somewhat higher odds of reaching a systolic blood pressure below 130 mmHg compared to those taking the same total dose once daily.19PubMed Central. Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety The differences weren’t enormous, and splitting the dose creates the obvious practical problem of having to remember a second pill. For most people, once-daily dosing works well enough. But if your blood pressure tends to creep up toward the end of the day, or if nocturnal blood pressure is a concern, splitting the dose is a conversation worth having with your prescriber.
The Uric Acid Bonus
Losartan has an unusual side benefit that isn’t shared by other drugs in its class: it lowers uric acid levels. It does this by inhibiting a kidney transporter called URAT1, which normally reclaims uric acid from urine and sends it back into the bloodstream.20PubMed. Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients By blocking this transporter, losartan allows more uric acid to leave the body through urine.
For people who have both high blood pressure and gout (or elevated uric acid without gout symptoms), this makes losartan a particularly attractive choice. A meta-analysis of randomized trials found that the uric acid reduction is broadly similar across the dose range studied, with no clear evidence that higher doses lower uric acid more than lower doses.21Hypertension Research. Urate-lowering effects of losartan: a meta-analysis of randomised controlled trials and target trial emulation In other words, you get this benefit at 50 mg just as much as at 100 mg, which is different from the blood-pressure-lowering effect where dose matters. This property belongs to losartan specifically and is not a class effect of all angiotensin receptor blockers, so switching to a different one would likely lose this uric acid benefit.
What Happens in Overdose
Losartan overdose, while serious in concept, tends to be less dangerous than overdoses with some other cardiovascular drugs. A review of 206 cases of angiotensin receptor blocker overdoses (including losartan) found that the majority of children who took too much remained symptom-free, with only about 17% developing minor symptoms. Among adults, roughly half had no symptoms, and another 38% experienced only minor effects like dizziness or mild low blood pressure. Moderate symptoms occurred in fewer than 9% of adults, and the review suggested that people who ingested less than five times the maximum daily dose could generally be monitored without hospital referral.22PubMed. Angiotensin II antagonists – an assessment of their acute toxicity
The picture gets more complicated when losartan is taken alongside other cardiovascular medications. A case report of a combined overdose with losartan and amlodipine (a calcium channel blocker) described severe drops in blood pressure requiring aggressive treatment with vasopressors and other interventions.23PubMed Central. Fifty-Four Tablets Too Many: A Case Report of Amlodipine and Losartan Overdose The danger in such scenarios comes primarily from the co-ingested drug rather than from losartan itself, but it underscores why anyone suspecting an overdose should seek emergency help regardless of the specific medication involved.
Why Losartan Dosing Feels Less Precise Than You’d Expect
If you’ve ever wondered why your doctor seems to “try” a dose and then adjust based on how you respond, rather than calculating an exact amount tailored to your body, the answer lies partly in the drug’s metabolism. Because losartan relies on a liver enzyme to create most of its active effect, and because that enzyme’s activity varies based on genetics, liver health, other medications, and even diet, the relationship between the dose you swallow and the effect on your blood pressure is less predictable than it is for drugs that work directly without metabolic conversion. Two people of the same weight and age, taking the same dose, can produce very different blood levels of the active metabolite E-3174.24PubMed Central. Influence of CYP2C9 Genetic Polymorphisms on the Pharmacokinetics of Losartan and Its Active Metabolite E-3174: A Systematic Review and Meta-Analysis
In practice, this means the dosing of losartan is a guided starting point followed by clinical monitoring. Your prescriber picks a reasonable initial dose based on your indication, liver status, and other medications, then checks your blood pressure and lab work after a few weeks. That feedback loop matters more than getting the initial number exactly right, which is why the standard advice is to start, watch, and adjust rather than to calculate a precision dose from the outset.

